Preprint · OA
via OpenAlex
RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer’s disease
Helen Wong, Josien Levenga, Peter Cain, Beverly A. Rothermel, Eric Klann, Charles A. Hoeffer
Acta Neuropathologica · 2015 · ▲ 89 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s00401-015-1499-8
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Wong, H., Levenga, J., Cain, P., Rothermel, B.A., Klann, E., & Hoeffer, C.A. (2015). RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer’s disease. <em>Acta Neuropathologica</em>. https://doi.org/10.1007/s00401-015-1499-8
Vancouver
Wong H, Levenga J, Cain P, Rothermel BA, Klann E, Hoeffer CA. RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer’s disease. Acta Neuropathologica. 2015. doi:10.1007/s00401-015-1499-8.
BibTeX
@unpublished{helen2015RCANov,
title = {RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer’s disease},
author = {Helen Wong and Josien Levenga and Peter Cain and Beverly A. Rothermel and Eric Klann and Charles A. Hoeffer},
journal = {Acta Neuropathologica},
year = {2015},
doi = {10.1007/s00401-015-1499-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurochemistry International 2004
Citation only
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease
Springer eBooks 2008
Citation only
Amyloid and Neurodegeneration: Alzheimer's Disease and Retinal Degeneration
Biogerontology 2014
Citation only
Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease
The Lancet Neurology 2016
Citation only
Alzheimer's disease risk: amyloid versus neurodegeneration
Neurobiology of Disease 2020
Open access · CC-BY
APOE in Alzheimer's disease and neurodegeneration
European Neuropsychopharmacology 2019
Citation only